Ozempic is dosed once a week and climbs in slow, four-week steps. Most people start at 0.25 mg for a month, move to 0.5 mg, and only then go higher if needed. The label allows 1 mg and 2 mg maintenance doses, but the point of starting low is not to treat anything at first. It is to give the digestive system time to adjust so the higher, effective dose can be reached without constant nausea.
What does the actual schedule look like?
The Ozempic label lays out a fixed titration. Weeks one through four are 0.25 mg once weekly. Weeks five through eight step up to 0.5 mg. If blood sugar needs more control after that, the dose can rise to 1 mg, and later to a maximum of 2 mg, each increase held for at least four weeks before the next. The OZEMPIC prescribing information spells this out for type 2 diabetes, which is the condition Ozempic is approved to treat.
Ozempic is a brand of semaglutide, the same active molecule sold as Wegovy for weight management. The doses differ. Wegovy escalates over more steps to a higher weekly ceiling, as the WEGOVY label describes. The FDA has published a plain reference on the medications containing semaglutide and what each is cleared for, which is worth reading before assuming one product’s schedule applies to another.
Why are the increases so slow?
Semaglutide is a GLP-1 receptor agonist. It slows how fast the stomach empties and acts on appetite signaling, which is also why the most common early side effects are nausea, vomiting, and loose stools. A review of the mechanisms of GLP-1 and dual receptor agonists explains why these gut effects show up: the same pathway that reduces appetite is the one that irritates the stomach when the dose jumps too quickly.
The four-week spacing is the whole strategy for managing that. Give the body a month at each rung and the nausea usually fades before the next increase. Rush it and you mostly add misery without adding benefit. That is the honest reason the schedule feels slow: patience early buys tolerance later.
How do the branded steps compare?
| Period | Typical Ozempic dose | Purpose of the step |
|---|---|---|
| Weeks 1 to 4 | 0.25 mg weekly | Run-in only, not a treatment dose |
| Weeks 5 to 8 | 0.5 mg weekly | First maintenance option |
| Week 9 onward | 1 mg weekly | Higher control if 0.5 mg is not enough |
| Later, if needed | 2 mg weekly | Label maximum for added glycemic effect |
A lot of people never reach 2 mg, and that is fine. If 0.5 mg or 1 mg holds blood sugar where it should be, staying there is reasonable. The goal is control at the lowest workable dose, not the biggest number the label allows.
What does the trial evidence say about dose and staying on it?
Most of the strongest data on semaglutide comes from weight-management trials at higher doses, but the lessons about the drug’s behavior carry over. The STEP 8 trial, published in JAMA in 2022, compared weekly semaglutide against daily liraglutide and reported larger weight loss with the weekly drug at its target dose. The STEP 3 trial paired the medication with intensive behavioral therapy and showed the two together outperformed behavior change alone.
The more sobering findings concern stopping. The STEP 4 trial randomized people who had already reached the maintenance dose either to continue or to switch to placebo, and those who stopped regained weight. A later STEP 1 extension tracked participants after full withdrawal and found much of the lost weight returned within a year. Reaching the top of the dosage schedule is not a finish line. The effect depends on continued treatment, which is a cost question as much as a medical one.
Where do self-pay and compounded routes fit?
Because staying on the drug matters, the monthly price shapes real decisions. Named telehealth and pharmacy programs, including Ro, Hims and Hers, Henry Meds, NovoCare, and LillyDirect, offer different mixes of branded and compounded products at different prices. Compounded semaglutide is not an FDA-approved product, it is prepared by a compounding pharmacy, and it can come in concentrations that do not match the branded pen, which means its schedule cannot simply be copied from the Ozempic label. Supervised practices that publish clear dosing information, such as one that lays out the standard Ozempic dosage schedule alongside its cash pricing, at least let a person see the plan before committing. Prescribing should still be handled by a licensed clinician who adjusts the steps to the individual.
One caution worth stating plainly: a low advertised first-month price means little if the sustainable monthly cost is what determines whether treatment continues long enough to work. Compare the ongoing number.
What about the newer options?
The field is not standing still. Orforglipron, an oral small-molecule GLP-1 receptor agonist studied in a trial reported in 2025, was approved by the FDA in 2026 for weight management under the brand FOUNDAYO. A pill on a different schedule is a meaningful shift for anyone who dislikes injections. It does not change how Ozempic itself is titrated, but it is a reminder that the once-weekly injectable schedule is one approach among several, not the only path.
Key takeaways
- Ozempic starts at 0.25 mg weekly as a run-in, then steps up every four weeks.
- The slow schedule exists to limit nausea, not to delay results for no reason.
- Many people do well at 0.5 mg or 1 mg and never need the 2 mg maximum.
- Trial data show weight tends to return after stopping, so ongoing cost is part of the plan.
- Compounded semaglutide is not FDA-approved and may not share the branded product’s concentrations.
Frequently asked questions
Why does Ozempic start at such a low dose?
The 0.25 mg starting dose is not meant to treat blood sugar. It is a run-in step that lets the gut adjust and reduces nausea before the dose climbs to a level that actually works.
How long does it take to reach a full dose?
The label moves in four-week steps, so reaching the 1 mg maintenance dose takes roughly two months, and reaching 2 mg takes longer. Many people stay at a lower dose if it controls their numbers.
Can the schedule be sped up?
It is not designed to be rushed. The four-week spacing exists to limit side effects. A prescriber may slow the schedule further if nausea is bad, but faster escalation mainly adds gut symptoms without adding benefit.
Is compounded semaglutide dosed the same as Ozempic?
Not necessarily. Compounded semaglutide is not an FDA-approved product and may come in concentrations that differ from the branded pen, so its dosing cannot be assumed to match the Ozempic label.
What happens if a dose is missed?
The label gives a window for taking a late weekly dose, but if too much time has passed the guidance is to skip it and resume on schedule. A prescriber decides whether re-titration is needed after a long gap.
